Statins: A New Hope on the Horizon of Graves Orbitopathy?

J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2819-e2821. doi: 10.1210/clinem/dgab184.

Authors

Michele Marinò¹, Giulia Lanzolla¹, Claudio Marcocci¹

Affiliation

¹ Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, 56124, Pisa, Italy.

PMID: 33735381
DOI: 10.1210/clinem/dgab184

No abstract available

Keywords: Graves orbitopathy; cholesterol; statins.

Publication types

Editorial
Comment

MeSH terms

Graves Disease*
Graves Ophthalmopathy* / drug therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors